Information Provided By:
Fly News Breaks for June 5, 2018
KKR, AMED
Jun 5, 2018 | 07:24 EDT
SunTrust analyst David MacDonald said he is "bullish" on Amedisys (AMED) following the repurchase of 2.4M shares from KKR (KKR), telling investors in a research note that the company's pristine balance sheet, strong free cash flow and expected near-term upsizing of the credit facility should give Amedisys plenty of dry power to ramp M&A activity. MacDonald raised his price target to $90 from $85 and maintained a Buy rating on the stock.
News For AMED;KKR From the Last 2 Days
KKR
Apr 26, 2024 | 16:08 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here
KKR
KKR
KKR
AMED
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.